News - Genentech


Current filters:


Popular Filters

37 to 60 of 60 results

ASCO 2012: "Show me the overall survival data," say analysts


The annual American Society of Clinical Oncology (ASCO) meeting, held this year in Chicago from June…

GenentechJohnson & JohnsonOncologyPharmaceuticalResearchRochetrastuzumab emtansineZytiga

Genentech links up with Ensemble Thera for macrocyclic drug candidates discovery


Swiss drug major Roche's (ROG: SIX) subsidiary Genentech has initiated a drug discovery collaboration…

BiotechnologyEnsemble TherapeuticsGenentechLicensingResearchRoche

Groundbreaking Alzheimer's prevention trial announced, as US debuts AD program


A collaboration of the US National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI), University…

crenezumabGenentechNeurologicalNorth AmericaPharmaceuticalPoliticsResearchRoche

US retinal therapeutics market buoyant, says F&S


Alarm bells are ringing loud and clear as diabetes has grown to epidemic proportions worldwide, triggering…

AvastinGenentechLucentisMarkets & MarketingNorth AmericaOphthalmicsPharmaceuticalRoche

Roche to file for trastuzumab emtansine this year, on positive Ph III results


Swiss drug major Roche (ROG: SIX) says that top-line results of EMILIA, the first randomized Phase III…


GSK settles with Genentech over ofatumumab patents


UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

Counterfeit Avastin found in USA by FDA


The US Food and Drug Administration said yesterday that it is warning health care professionals and patients…

AvastinGenentechMarkets & MarketingNorth AmericaOncologyPharmaceuticalRegulationRoche

Faster-than-expected FDA approval of Roche’s vismodegib


There was good news for Swiss drug major Roche's (ROG: SIX)subsidiary Genentech yesterday, when it received…

BiotechnologyCurisErivedgeGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Roche in epigenetics drug discovery collaboration


USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

Xenon in $646 million deal with Roche unit


Canada based Xenon Pharmaceuticals, a privately-owned, clinical genetics-based drug discovery and development…

BiotechnologyGenentechLicensingNeurologicalPharmaceuticalResearchRocheXenon Pharmaceuticals

Vernalis jumps on deal with Genentech


The UK's Vernalis (LSE: VER) saw its shares jump more than 5% to 20.75 yesterday, after the company revealed…


Inhibitors of infamous Ras oncogene reported by Genentech researchers


A drug discovery team at Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) has uncovered a…


US FDA revokes Roche/Genentech Avastin license for metastatic breast cancer


After months of deliberations, the US Food and Drug Administration (FDA Commissioner is revoking the…

AvastinBiotechnologyGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

US court rules in GlaxoSmithKline’s favor in Arzerra patent dispute


A US District Court has entered final judgment in favor of UK pharma giant GlaxoSmithKline (LSE: GSK)…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceuticalRoche

FDA priority review for Roche/Genentech’s vismodegib for skin cancer


The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Genentech files with US FDA for vismodegib in rare form of advanced skin cancer


In a second filing for a novel skin cancer drug this year, Swiss drug major Roche (ROG: SIX) US subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Galapagos units extend drug discovery collaboration with Genentech


Galapagos units extend drug discovery collaboration with Genentech August 19, 2011 Belgium-based…


US Nevada state judge denies Roche and Genentech motions to dismiss PDL BioPharma's royalties complaint


The Second Judicial District Court of US state Nevada ruled in favor of PD BioPharma (Nasdaq: PDLI) on…

BiotechnologyGenentechLegalNorth AmericaOncologyPDL BioPharmaPharmaceuticalRoche

Roche’s Genentech in preclinical cancer program deal with FORMA Therapeutics


Cambridge, Massachusetts, USA-based small-molecule therapeutics developer FORMA Therapeutics has entered…

BiotechnologyFORMA TherapeuticsGenentechLicensingOncologyPharmaceuticalRoche

Roche files for US and EU approval of vemurafenib for metastatic skin cancer


US biotech giant Genentech, part of Swiss drug major Roche (SIX: ROG), has submitted a New Drug Application…

Bristol-Myers SquibbDaiichi SankyoEuropeGenentechNorth AmericaOncologyPharmaceuticalPlexxikonRegulationRochevemurafenibYervoy

37 to 60 of 60 results

Back to top